Your browser doesn't support javascript.
loading
Cabazitaxel versus docetaxel for treatment of metastatic castrate refractory prostate cancer.
James, Nicholas D; Ali, Ayesha; Pope, Ann; Desai, Amisha; Ford, Daniel; Stevenson, Robert; Zarkar, Anjali; Pirrie, Sarah.
Afiliação
  • James ND; Institute of Cancer Research London UK.
  • Ali A; Cancer Research UK Clinical Trials Unit (CRCTU) University of Birmingham Birmingham UK.
  • Pope A; Cancer Research UK Clinical Trials Unit (CRCTU) University of Birmingham Birmingham UK.
  • Desai A; University Hospital Birmingham Cancer Centre, University Hospital Birmingham Birmingham UK.
  • Ford D; University Hospital Birmingham Cancer Centre, University Hospital Birmingham Birmingham UK.
  • Stevenson R; University Hospital Birmingham Cancer Centre, University Hospital Birmingham Birmingham UK.
  • Zarkar A; University Hospital Birmingham Cancer Centre, University Hospital Birmingham Birmingham UK.
  • Pirrie S; Cancer Research UK Clinical Trials Unit (CRCTU) University of Birmingham Birmingham UK.
BJUI Compass ; 3(6): 484-493, 2022 Nov.
Article em En | MEDLINE | ID: mdl-36267204
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: BJUI Compass Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: BJUI Compass Ano de publicação: 2022 Tipo de documento: Article